Neal C. Bradsher, 10% Owner at OncoCyte Corp (OCX), bought 1,050,000 shares at $2.27 ($2.4M) on 2020-04-24, disclosed to the SEC on 2020-04-28.
Open-market purchase of $2.4M OCX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-11-21 | $82.1M | — | Filing → |
| STAA | BUY | 2025-04-10 | $5.4M | — | Filing → |